ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 646278 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 646278; 2) Community: the network communities that were significantly associated with the response to NSC 646278; 3) Molecule: the relationships between components within communities and NSC 646278; 4) MDR: the compounds that were significantly associated with the NSC 646278.

NSC Compound Enrichment Correlation
NSC 670784 Null 0.013789112253851 0.3424192
NSC 112846 N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid 0.0171490505199913 0.47718116
NSC 128687 6H-Furo[2',3':4,5]oxazolo[3,2-a]pyrimidine-2-methanol, 2,3,3a,9a-tetrahydro-6-imino-3-(phosphonooxy)-, (2R-(2.alpha.,3.beta.,3a.beta.,9a.beta.))- (9CI) 0.0171490505199913 0.6169025
NSC 179074 Lead, bis[(2-cyanoethyl)cyclohexylcarbamodithioato-S,S']-, (T-4)- 0.0171490505199913 0.35353951
NSC 33577 Null 0.0171490505199913 0.3293262
NSC 343499 CI-921: amsacrine derivative 0.0171490505199913 0.69941975
NSC 610457 Camptothecin Derivative 0.0171490505199913 0.66071894
NSC 618296 Null 0.0171490505199913 0.10807872
NSC 633497 Null 0.0171490505199913 0.083490649
NSC 644221 Null 0.0171490505199913 0.64322333
Total:92  Current:36    [First] [Prev] [Next] [Last]